Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

XenoPort, Inc. announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $19.00 per share. XenoPort has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any. All of the shares are being offered by XenoPort. Morgan Stanley and Co. Incorporated and Goldman, Sachs and Co. are acting as joint book-runners for the offering.

Today in Popular Press...keeping you current

A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09

Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09

Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address